[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 1960


Am J Dis Child. 1960;100(5):656. doi:10.1001/archpedi.1960.04020040658003

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


An unfortunate error appeared in the Seminar article in the September, 1960, American Journal of Diseases of Children which was entitled "Congenital Virilizing Adrenal Hyperplasia," page 422 of this volume. Under a discussion of therapy, the author states that "... desoxycorticosterone acetate (Percorten) 25 mg/cc. may be employed intramuscularly every 25 to 30 days. The dose is 1 cc. every 25 to 30 days...." The statement should read "Desoxycorticosterone trimethylacetate (Percorten trimethylacetate) 25 mg/cc. may be employed intramuscularly every 25 to 30 days." DCA trimethylacetate is the long-acting derivative which may be given every 25 to 30 days. Desoxycorticosterone acetate is the "short-acting" form which is given daily in doses of 1 to 2 mg. We suggest you clip this item and insert it at page 422.

First Page Preview View Large
First page PDF preview
First page PDF preview